Justin G. Model Memorial Golf Outing to Benefit the Brain Injury Research Center at Mount Sinai

Justin Model golfing in Miami

Justin golfing in Miami

Justin and Steph in Italy, 2023

Justin and Steph in Italy, 2023

Justin’s father, Hal, mother Ricki, uncle Robert, and brother Jared on the golf course

From left, Justin’s father, Hal, mother Ricki, uncle Robert, and brother Jared on the golf course

Justin’s aunt Sabrina (with his mother, Ricki, at the event.

Justin’s aunt Sabrina (left) with his mother, Ricki, at the event

“Make every day count.”

This is the message Justin Model’s family believes he would have wanted others to hear. This is how Justin lived his life. A bright and ambitious 33-year-old, Justin was a rising star at ING known for mentoring colleagues and his deep passion for building connections and sharing knowledge. A central facet of Justin’s life was his love for companionship and adventure; he was an avid golfer, traveler, and thrill-seeker, embracing every moment to its fullest.

Justin’s fiancé, Steph, articulated his character: “Justin loved being around people and could make friends with anyone from any walk of life. He was someone who made the most of every day and wanted to take on new adventures.”

In April 2024, Justin suffered a devastating brain bleed and was taken to The Mount Sinai Hospital. Despite great medical care, Justin did not recover, leaving behind his family, his fiancé, and a multitude of friends and colleagues who treasured his spirit and zest for life.

After the tragedy, Justin’s family was determined to honor his memory and quickly established the Justin G. Model Foundation to support brain injury research.

They agreed that a golf outing fundraiser was the most fitting way to gather together, as Justin had an unrivaled passion for the sport, played all over the world, and even once made a hole-in-one. “If he could have played golf every single day, he probably would have. And he was damn good at it. So that’s how it came about,” Justin’s mother, Ricki, said.

With the generous sponsorship of ING, Justin’s family and friends hosted the inaugural Justin G. Model Memorial Golf Outing this past April at Fiddler’s Elbow Country Club in Bedminster, New Jersey. With 180 guests, the Foundation raised $70,000 for the Brain Injury Research Center (BIRC) at Mount Sinai.

The outing served as a joyful gathering where friends and family reminisced about the good times they had with Justin and the joy he brought to everyone around him. “I think for us, the outing was a really good way to bring people together and have fun in his name. That’s what Justin would have wanted. Were there some tears? Absolutely, but there were a lot of laughs. It was about bringing people together, having fun, remembering the good times, and doing something that he loved,” Steph reflected.

Ricki shared how developing the foundation and planning the outing provided a channel not only to remember Justin but also to make a positive impact. “It also gives me a way of keeping his name alive, saying his name every day, and being able to help others and prevent what happened to us. As a mother, I would want to do everything to prevent this.”

“We are profoundly thankful to the Model family for their generosity and for choosing to honor Justin’s life with this tribute golf outing,” said BIRC Director Kristen Dams-O’Connor, PhD, who is also the Jack Nash Professor and Vice Chair of Research in the Department of Rehabilitation and Human Performance, and Professor of Neurology and Neuroscience at the Icahn School of Medicine at Mount Sinai. “Their support will undoubtedly have a far-reaching impact, benefiting countless individuals and families affected by brain injuries.”

The Model family’s commitment to promoting awareness and funding for brain injury research ensures Justin’s memory lives on while advancing the science that could save and improve lives in the future, further solidifying Justin’s positive impact on the world. Plans are underway for next year’s golf outing, with the goal of increasing participation and funding.

“We want to keep Justin’s name front of mind for everyone who knew him and for everyone who didn’t get a chance to know him. Hopefully, with the funds that we’re raising, we can help another family not experience the loss that we’ve experienced,” Ricki said.

In Steph’s words, “I believe Justin’s message would be that you don’t know how long you’re going to have, so make the most of the days that you do have. If you do that, you’re going to live a happy life.”

Connect with the Justin G. Model Foundation on social media:

From athletic events to special celebrations, we have endless opportunities to support Mount Sinai, and we are here to help you! Please contact Whitney Cortes at Whitney.Cortes@mountsinai.org or (646) 877-4784.

A Touchdown for Children’s Health: The Why Not You Foundation’s Game Changing Support for Mount Sinai Kravis Children’s Hospital

Ciara and Russell Wilson’s Why Not You Foundation is bringing its winning spirit to Mount Sinai Kravis Children’s Hospital. The connective power of philanthropy started with the Jack Martin Fund, a long-time contributor to the Jack and Lucy Clark Department of Pediatrics and Mount Sinai Kravis Children’s Hospital, who introduced Russell and Ciara to Mount Sinai when the NFL quarterback signed with the New York Giants and was seeking a children’s hospital to support in his new hometown. Supporting children’s health is a mission that deeply resonates with the husband and wife Super Bowl champion and Grammy award-winning singer; their foundation’s mission is to “Encourage and challenge today’s youth to embrace opportunities, overcome obstacles and make a positive impact throughout their lives.”

This isn’t the first time the NFL New York Giants quarterback has made an impact at Mount Sinai. A decade ago, after Russell’s Super Bowl XLVIII victory, Mount Sinai’s leaders first met Russell Wilson, and he recently returned for a visit that brought unforgettable joy to the hospital’s halls. Russell spent time with children, families, and staff, leaving a lasting impression on everyone he met.

When visiting Mount Sinai, Russell made a surprise appearance at the Emergency Medicine White Coat Ceremony, where residents received their “white coats” as a symbolic transition into the specialty, and where Russell was donned with an honorary coat himself. From there, Russell headed to the Child Life KidZone where he played air hockey, signed copies of their New York Times bestseller children’s book, Why Not You? he and Ciara co-authored, and connected with young patients. Check out the smiles and cheers brought to everyone Russell met at Mount Sinai:

 

 
 
 
 
 
View this post on Instagram
 
 
 
 
 
 
 
 
 
 
 

 

A post shared by Mount Sinai Health System (@mountsinainyc)

The Why Not You Foundation’s statement of future support comes at a pivotal time for Mount Sinai Kravis Children’s Hospital. The hospital is in a transformative period of growth, making major investments in technology, talent, and new clinical and surgical units to enhance the young patient and family experience. This expansion is designed to meet both the medical and emotional needs of the children and families we serve.

The philanthropic partnership kicked off at the Foundation’s $3 Million Dollar Dinner on Monday, August 18th, on the Giants’ 50-yard line at MetLife Stadium, with Fortune 100 companies, top corporate executives, community leaders, and nonprofit partners in attendance. Guests were treated to an extraordinary culinary experience curated by Iron Chef Masaharu Morimoto and the ambiance was elevated by a live performance by Musicians from the New York Philharmonic. Adding a touch of wonder and excitement, Anna DeGuzman, a trailblazing Filipina-American magician, cardist, and mentalist, wowed the crowd with a captivating magic show. The evening was emceed by Anthony Ramos, Grammy award-winning actor, singer, and arts advocate whose energy and charisma kept the crowd engaged throughout. A highlight of the night was a heartfelt speech from Lisa M. Satlin, MD, System Chair of the Jack and Lucy Clark Department of Pediatrics and Pediatrician-in-Chief of Mount Sinai Kravis Children’s Hospital, who spoke passionately about the transformative impact of the Why Not You Foundation’s partnership with Kravis Children’s Hospital and the importance of continued investment in pediatric care.

As Russell and Ciara beautifully state in their book, Why Not You, “Your potential has no boundaries!” Together with the Why Not You Foundation, Mount Sinai is proving that there is no endeavor too big when it comes to creating a brighter, healthier future for children and anticipating a partnership that will better the lives of countless young people coming to Mount Sinai’s Kravis Children’s Hospital in years to come.

The Jeremy H. Boal Endowed Fund: A Legacy of Compassion and Care at Mount Sinai

In a touching ceremony attended by family, friends, and colleagues, the Mount Sinai Health System recently announced the establishment of the Jeremy H. Boal, MD, MSH ’96, Endowed Fund in recognition of Dr. Boal’s extraordinary career and enduring impact. The Fund ensures vital support for the Mount Sinai Visiting Doctors Program, which Dr. Boal co-founded in 1995 with Drs. David Muller and Laurent Adler, and the Hospice and Palliative Care Fellowship at the Brookdale Department of Geriatrics and Palliative Medicine.

From his training as a Brookdale Fellow to his leadership roles, including Executive Vice President and Chief Clinical Officer of the Mount Sinai Health System, Dr. Boal’s career exemplifies a deep commitment to improving health care for the most vulnerable. He played a pivotal role in Mount Sinai’s response to the COVID-19 pandemic and championed initiatives addressing access to care.

“I’ve had the opportunity to be a part of Mount Sinai in so many ways. I’ve had clinical, academic, operational, and strategic responsibilities. I’ve been responsible for maintaining and improving the quality and safety of the entire Health System at times. It’s been a joy to have had the chance to do all of those things and learn so much.”
–Jeremy H. Boal, MD, MSH ’96

In 2023, Dr. Boal received a diagnosis of amyotrophic lateral sclerosis (ALS), the neurodegenerative disease commonly known as Lou Gehrig’s disease. Yet, even as he stepped down from his formal roles at Mount Sinai to focus on his health, Dr. Boal remains dedicated to a lifelong pursuit of compassion, empathy, and care as an active advocate for medical aid-in-dying legislation. Read Dr. Boal’s recently published essay here.

(Update: as of June 9, 2025, the New York State Senate passed the Medical Aid in Dying Act, the first time this has happened since the legislation was introduced in 2016. If signed into law by Governor Hochul, New York will become the 12th state to authorize this end-of-life care option.)

 

In His Own Words: Dr. Boal Reflects Upon a Career of Curiosity and Compassion

From left: Drs. David Muller, Laurent Adler, and Jeremy Boal, circa 1996

“I came to Mount Sinai in the early nineties as a second-year internal medicine resident. During my residency, I was curious about a number of patients in our practices who clearly needed care but were missing appointments. David Muller and I came up with the idea to use some elective time to track down some of these patients and ask them if we could go visit them in their homes to try to figure out what the gaps were in accessing care.

Even as busy as residencies are, I was developing this incredible curiosity and passion for understanding how the system works or doesn’t work and figuring out how to make it work better. That’s how the Visiting Doctors Program was started—with the intention of creating a clinical platform to bring care to patients in our communities who had great difficulty or simply couldn’t come to the hospital or our practices to get care.

When we proposed this idea to our residency director, Dr. Larry Smith, our chair of medicine, Dr. Barry Coller, and to other leaders, there was an interest and a willingness to explore it with us while recognizing that it was a daunting goal.

The response we got was: “let’s figure this out, and if you hit roadblocks, come tell us and we will help you.” It was a combination of us and our curiosity and our desire to make things better. And being lucky to be at a place like Mount Sinai that embraces taking on hard challenges. Mount Sinai has always been a place of profound curiosity and a willingness to try new things.

Since then, the program has operated continuously, caring for tens of thousands of New Yorkers all over Manhattan, significantly impacting those most vulnerable and at risk of losing access to care.

Being at Mount Sinai for most of my career and then having a chance to step away gave me an opportunity to gain a lot of insight into what makes Mount Sinai truly unique and truly special. In addition to the intense curiosity that is part of Mount Sinai’s DNA, another key characteristic is an absolute commitment to excellence and an intolerance for mediocre outcomes. If you work at Mount Sinai, you’re working at a place where we demand the best possible outcome for every patient and for our communities. And we are not afraid to be clear about that, we’re not afraid to take on really tough challenges.

Over the years, we’ve become a health system with many assets, hospitals, ambulatory sites, and virtual care, but we’ve never lost track of our vital mission and values. COVID was an extraordinary challenge and bearing witness to so much pain and suffering and so much loss transformed us as an organization. We had to flatten our hierarchy even more, create a structure where we could react and proactively act to address unpredictable challenges, at the speed at which they were occurring and experiment our way forward. This approach allowed us to save many more lives and protect our staff to a much greater degree.

Dr. Boal, front row, second from left, celebrates the 2017 opening of the Mount Sinai-Union Square Urgent Care with Mount Sinai leaders, local politicians, and community organizers

I’ve had the chance to spend decades working with extraordinary people on the most important mission of all: to create a world in which everybody can live the longest and healthiest, most disability-free life possible. There’s a unique ecosystem at Mount Sinai. It’s grounded in its values and in this commitment to collaborative discovery that allows for the creation of miracles, of extraordinary change. I’ve been witness to that for decades. I’m blown away by what our medical school creates. I’m blown away by what our hospitals and our ambulatory environments create and what they deliver. There’s just a fire in the belly of this organization to not accept the status quo. And that fills me with joy and gratitude.”

The above is excerpted from an interview with Dr. Boal upon receiving the 2024 Jacobi Medallion, the highest award bestowed upon a member of the Mount Sinai community.

 

“We celebrate Dr. Boal for what he has done, but also for who he is; for his clinical brilliance, his leadership, his tenacity, his kindness, his thoughtfulness, his friendship, his fervent belief in equity, and for simply doing the right thing for everyone around him every time—even during the most difficult circumstances.”

Brendan G. Carr, MD, MA, MS, Chief Executive Officer, Professor and Kenneth L. Davis, MD, Distinguished Chair, Mount Sinai Health System

“Jeremy’s empathy for people and human suffering is the foundation that drove all of the work that he’s done over the course of his career. He has such empathy for human suffering. There are no awards for that.”

David Muller, MD, MSH, ’95, Dean Emeritus for Medical Education, Director, Institute for Integrity and Justice in Medical Education, Icahn School of Medicine at Mount Sinai, Co-founder of MSVD with Dr. Boal


About the Jeremy H. Boal, MD, MSH ’96, Endowed Fund

Through the establishment of the Jeremy Boal Endowment, Mount Sinai not only celebrates Dr. Boal’s remarkable achievements but also fortifies the future of initiatives that embody his values. This fund is a cornerstone for advancing health care delivery and education, ensuring our most vulnerable patients receive the high-quality, compassionate care they deserve.

The Fund supports the Mount Sinai Visiting Doctors Program and the Hospice and Palliative Care Fellowship at the Brookdale Department of Geriatrics and Palliative Medicine.

While certain aspects of the Visiting Doctors program’s invaluable work are covered by insurance, many vital services—such as social work and caregiver support—depend on generous philanthropic contributions. The Jeremy Boal Endowed Fund ensures the sustainability of this transformative program, allowing it to amplify its reach and magnify its impact on the lives of homebound individuals and their caregivers. Generous support from donors helps Mount Sinai continue to be national leaders in home-based primary care.

About the Mount Sinai Visiting Doctors Program

Now in its 30th year, the program serves more than 1,000 homebound patients annually, providing compassionate, multidisciplinary care that addresses complex medical and social needs. The MSVD team—comprising physicians, nurses, social workers, and dedicated administrative staff—delivers personalized, multidisciplinary care directly to patients in their homes. This innovative approach encompasses not only physical examinations and medical management but also helps patients navigate essential resources and support systems, enabling them to remain in the comfort of their own homes. By doing so, MSVD has set a national standard in home-based primary care.


About the Hospice and Palliative Medicine Fellowship

Additionally, the endowed fund supports the Brookdale Fellowship, fostering the next generation of leaders in geriatrics and palliative medicine. Palliative care is specialized medical care for people living with a serious illness and is appropriate at any age and at any stage in a serious illness, and it can be provided along with curative treatment. This fellowship empowers physicians to meet the distinctive needs of ill and/or aging populations, an area where Dr. Boal has made significant strides. His legacy serves as a powerful inspiration for emerging clinicians, researchers, and advocates dedicated to providing holistic and compassionate care.


To learn more or contribute to the Jeremy Boal Endowed Fund, please contact Bryce Shaffer, Associate Director of Development, at bryce.shaffer@mountsinai.org or 929-637-3399. Together, we can honor Dr. Boal’s legacy and continue his mission of transforming care for generations to come.

Empowering Women’s Health: Highlights from the Dubin Breast Center’s Annual Fact vs. Fiction Luncheon and Symposium

On May 12th, the Dubin Breast Center hosted its annual Fact vs. Fiction Luncheon and Symposium at the Metropolitan Club, providing a platform to discuss advancements in breast cancer care and women’s health. A distinguished panel of experts from Mount Sinai engaged an audience of more than 200 attendees, including Dubin Breast Center advisory board members, patients, families, and friends, with their insights into the latest innovations and emerging trends in breast health.

The event was led by visionary Mount Sinai Health System Trustee, Eva Andersson-Dubin, MD, who established the Center in 2011, alongside Elisa Port, MD, FACS, Chief of Breast Surgery and Director of the Center. Among the highlights was the inspiring story of Vanessa Rissetto, a Dubin Breast Center patient, registered dietitian, and CEO of Culina Health. Her journey resonated deeply with the crowd, illustrating resilience and hope in the face of adversity.

Watch Vanessa’s full story in the event recording here:

In her opening remarks, Dr. Port painted a vivid picture of the Center’s advancements, emphasizing the integration of artificial intelligence in preventive breast care. “We continue to harness new technologies so that AI works for us, not instead of us,” she stated, reassuring the audience that their mammogram experience would remain personal—“You will never show up and be greeted by a robot.”

“We treat more than just breast cancer; we care for the whole person—mind, body, and spirit,” Dr. Port affirmed, setting the tone for an engaging discussion. The panel, which included esteemed Mount Sinai experts Susan S. Khalil, MD, Laurie Margolies, MD, FSBI, FACR, Jeffrey I. Mechanick, MD, PhD (hc), Georges Naasan, MD, Amy Tiersten, MD, and Christina Weltz, MD, explored vital topics ranging from gynecological care and IVF to the cognitive changes that accompany menopause and the innovative role of AI in imaging.

Their diverse insights created a rich tapestry of perspectives on women’s health throughout every stage of life, making the event not just informative but truly transformative. Together, they illuminated a path in women’s health care that prioritizes innovation, compassion, and holistic well-being.

In post-event communications, Drs. Port and Andersson-Dubin encouraged attendees to share the video with friends and family, and we hope you will do the same.

Outlined below are some of the essential insights presented at the event and featured in the video:
  • Gynecologic Care: Dr. Khalil discussed the management of menopausal symptoms, emphasizing a precision approach and the importance of understanding the most bothersome symptoms and tailoring treatment accordingly. Options include non-hormonal medications for vasomotor symptoms, hormonal treatments, and addressing vaginal symptoms with moisturizers, lubricants, and pelvic floor physical therapy.
  • Weight Management: Dr. Mechanick discussed the role of GLP-1 medications in reducing the risk of breast cancer. He explained that these medications, originally developed for diabetes, have shown effectiveness in weight loss, which is crucial as excess weight is a known risk factor for breast cancer. He emphasized the importance of a healthy eating pattern, regular exercise, and progressive resistance training to preserve muscle mass and reduce cancer risk. Dr. Mechanick also highlighted the need for personalized conversations with doctors about using these medications.
  • Personalized Treatment Plans: Dr. Tiersten discussed the importance of neoadjuvant (essentially “pre-surgery”) therapy in breast cancer treatment. She explained that administering systemic therapy, such as chemotherapy or immunotherapy, before surgery allows doctors to see how well the treatment works. This provides crucial information about prognosis and helps determine the best post-surgery treatment plan. Dr. Tiersten emphasized that this approach is particularly beneficial for HER2-positive and triple-negative breast cancer patients, as it significantly reduces the risk of recurrence.
  • Chemo Brain: Dr. Naasan explained that cognitive symptoms around menopause are common and may be related to a loss of estrogen. He noted that these symptoms are typically mild and often go away later. Dr. Naasan also mentioned that breast cancer treatments, particularly those that lower estrogen, can contribute to cognitive changes and what some patients refer to as “chemo brain.”
  • Heart Health: The experts underscored the importance of cardiovascular health in breast cancer patients. Dr. Margolies noted that AI algorithms are being developed to detect breast artery calcifications, which can indicate cardiovascular disease risk. This is crucial as more women are dying from cardiovascular disease than from breast cancer.
  • AI Imaging: Dr. Margolies also discussed the advancements in AI imaging, particularly in mammography. AI algorithms are improving in detecting smaller cancers and reducing false positives. They are also used to compare with prior images and detect cardiovascular disease risk.
  • IVF: Drs. Khalil and Weltz discussed the role of IVF in breast cancer patients, noting that IVF is often performed in conjunction with an aromatase inhibitor to keep estrogen levels down—an approach that is effective in preserving fertility while minimizing the risk of breast cancer recurrence.

About the Dubin Breast Center
From our inception, the Dubin Breast Center has had an enduring mission to treat and care for every patient regardless of their ability to pay, in a tranquil, soothing environment designed to promote healing, with compassionate caregivers who are with them on every step of their medical journey. We treat everyone individually and holistically, intending to alleviate fears and worries, enrich lives, and support well-being.

We see between 180 and 200 patients a day. In 2024, our team provided 12,000 mammograms, operated on 900 women and men, and proudly provided cold-capping services to 500 women. The Center recently surpassed 400,000 patient visits, encompassing imaging, surgery, and treatment services.

Philanthropy is essential in advancing our bold and ambitious vision. It ensures that the Dubin Breast Center of the Tisch Cancer Institute is one of the premier breast cancer treatment centers in New York City and beyond.

Mount Sinai’s 40th Annual Crystal Party Honors Dean Dennis S. Charney, MD

Accented by a sparkling springtime sunset overlooking the Hudson River, the Mount Sinai Health System held its 40th annual Crystal Party celebration at Pier Sixty in Chelsea Piers on May 20.

The evening was a smashing success, raising $5 million and bringing together more than 960 guests including family, friends, Health System leadership, Trustees, staff, and other supporters. This year’s event, which was chaired by Anne and Joel Ehrenkranz and Jana Pasquel de Shapiro and Adam Shapiro, honored Dennis S. Charney, MD, who will step down on June 30 after 18 years of leadership and service as the Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs.

“Dennis has been a transformative leader for the Icahn School of Medicine at Mount Sinai,” Trustee Joel Ehrenkranz told the crowd. “When he became Dean in 2007, the School was well-respected. Today, after 18 years of Dennis’ leadership, the Icahn School of Medicine is one of the best medical schools in the country.”

During the event, it was announced that the Depression and Anxiety Center for Discovery and Treatment at Mount Sinai would be renamed the Dennis S. Charney, MD Depression and Anxiety Discovery Center to honor Dr. Charney, a preeminent expert in neurobiology who has made fundamental contributions to the understanding of human anxiety, fear, depression, and resilience. Having played a key role in the discovery of new treatments for mood and anxiety disorders, Dr. Charney was recently named one of the 2025 TIME 100 Most Influential People in Health for his breakthrough treatments for depression.

Attendees were captivated by a video tribute that painted an intimate and inspiring portrait of Dr. Charney’s remarkable journey and impactful legacy.

Brendan G. Carr, MD, MA, MS, Chief Executive Officer and Kenneth L. Davis, MD, Distinguished Chair of the Mount Sinai Health System, saluted Dr. Charney as someone who “personifies Mount Sinai’s sense of mission and our spirit of invincibility,” adding that “his success is widely recognized, far beyond the halls of Mount Sinai.”

Much to the delight of Dr. Charney—an avid New York sports fan—Dr. Carr then queued up personalized video tributes from New York Yankees Hall of Famer Mariano Rivera and New York Knicks legend Walter “Clyde” Frazier.

“Congratulations on 18 winning seasons as Dean of Icahn School of Medicine at Mount Sinai,” Rivera said. “And I thank you and your team for all the jobs that you have done to advance science and medicine and bring blessings and good health to all New Yorkers. All New Yorkers congratulate you. You are the best, Dennis.”

Frazier flashed his two NBA championship rings and congratulated Dr. Charney with his familiar, inimitable flair. “They tell me that you were quite the basketball player back in the day—dishin’ and swishin, boundin’ and astoundin’ opponents across Long Island,” Frazier said. “But I appreciate that you brought your greatest game to medicine and science. Kudos and bravos for sure, for 18 years of grandeur, as Dean of the School.”

“Dennis Charney is to science and medicine what every professional sports team would love to have: An all-star player, coach, and general manager—all wrapped up in one exceptional person,” said Richard A. Friedman, Co-Chairman of the Boards of Trustees at the Mount Sinai Health System.“

“Mount Sinai has an extraordinary commitment to serving its community,” said Adam Shapiro, also a Trustee of the Health System. “Sinai reaches far and wide to serve over six million patients per year. It serves people in need, and it serves them with the same compassion and cutting-edge care that all patients receive. Its exemplary standards are those of a world-class academic medical center. And many of those standards were set by Dennis Charney.”

In his remarks, Dr. Charney referenced the 1904 opening of The Mount Sinai Hospital’s first building on Fifth Avenue and how its then-president, Isaac Wallach, characterized Mount Sinai as a “House of Noble Deeds.”

“This holds true today,” said Dr. Charney, who will remain on the faculty at the Icahn School of Medicine and plans to continue writing, researching, and mentoring. “Our team has the talent. We have the drive. We have the spirit of collaboration. And we have the technology. These are the essential elements that will enable us to keep climbing the mountaintops of scientific discovery—and to write new chapters of biomedical innovation in the epic history of this House of Noble Deeds.”

Proceeds raised at the Crystal Party fund a variety of programs and departments across the Icahn School of Medicine and the Mount Sinai Health System. Thank you for your support.

Celebrating Visionaries in Prostate Cancer Research at the 2025 Gala

On Thursday, April 10th, the Milton and Carroll Petrie Department of Urology hosted its annual Prostate Cancer Research Gala at New York’s storied Rainbow Room in Manhattan. The evening celebrated the extraordinary patients, physicians, scientists, and caregivers committed to advancing prostate cancer research and care. Raising close to $1.3M, the event was a testament to the power of community and shared purpose.

“As we stand here tonight, remember that each step, each discovery, and each act of generosity propels us towards a better future. Together, we’re igniting hope and transforming challenges into victories. I invite you to join us in this ongoing journey. Every bit of support brings us closer to a day when prostate cancer is a story of the past, not a battle in the present,” said Ash Tewari, MBBS, MCh, Chair of the Department of Urology at the Mount Sinai Health System and the Kyung Hyun Kim, MD Professor of Urology at Icahn Mount Sinai, who spearheaded the gala and directs the Center of Excellence.

At the event, Sybil and David Yurman were honored with the Visionary Award for their exceptional commitment to philanthropy and dedication to improving men’s health. Dr. Tewari praised the Yurmans’ unwavering support of the Mount Sinai Health System, highlighting their role as true visionaries in the field.

The third annual Steven Southwick, MD Memorial Award was presented to Natasha Kyprianou, PhD. Named after renowned researcher and scientist Steven M. Southwick—a leading expert in psychological trauma and human resilience, who passed away in 2022 after a lengthy battle with prostate cancer—this award recognizes outstanding achievements in prostate cancer research. Dr. Kyprianou was recognized for her focus on groundbreaking research that continues to push the boundaries of what is possible in the fight against prostate cancer.

“What really drives research is what drives me since I was very young—the effort to reduce suffering of any kind… Not only to give back, but to do whatever we can as scientists, as physicians, as human beings—to help reduce the suffering of other people,” Dr. Kyprianou said of her passion for advancing scientific discovery for prostate cancer.

Ash Tewari, Sybil Yurman, David Yurman

It is estimated that more than 300,000 men will be diagnosed with prostate cancer this year and more than 35,000 will die from this devastating cancer. The Prostate Cancer Research Gala is one of Mount Sinai’s signature fundraising events, providing the opportunity to celebrate our generous community of donors and partners committed to finding a cure.